176 related articles for article (PubMed ID: 28186401)
1. Chemoproteomic Screening of Covalent Ligands Reveals UBA5 As a Novel Pancreatic Cancer Target.
Roberts AM; Miyamoto DK; Huffman TR; Bateman LA; Ives AN; Akopian D; Heslin MJ; Contreras CM; Rape M; Skibola CF; Nomura DK
ACS Chem Biol; 2017 Apr; 12(4):899-904. PubMed ID: 28186401
[TBL] [Abstract][Full Text] [Related]
2. Chemoproteomics-enabled covalent ligand screen reveals a cysteine hotspot in reticulon 4 that impairs ER morphology and cancer pathogenicity.
Bateman LA; Nguyen TB; Roberts AM; Miyamoto DK; Ku WM; Huffman TR; Petri Y; Heslin MJ; Contreras CM; Skibola CF; Olzmann JA; Nomura DK
Chem Commun (Camb); 2017 Jun; 53(53):7234-7237. PubMed ID: 28352901
[TBL] [Abstract][Full Text] [Related]
3. Chemoproteomics-Enabled Covalent Ligand Screening Reveals ALDH3A1 as a Lung Cancer Therapy Target.
Counihan JL; Wiggenhorn AL; Anderson KE; Nomura DK
ACS Chem Biol; 2018 Aug; 13(8):1970-1977. PubMed ID: 30004670
[TBL] [Abstract][Full Text] [Related]
4. Chemoproteomics-Enabled Covalent Ligand Screening Reveals a Thioredoxin-Caspase 3 Interaction Disruptor That Impairs Breast Cancer Pathogenicity.
Anderson KE; To M; Olzmann JA; Nomura DK
ACS Chem Biol; 2017 Oct; 12(10):2522-2528. PubMed ID: 28892616
[TBL] [Abstract][Full Text] [Related]
5. Structural and Functional Analysis of a Novel Interaction Motif within UFM1-activating Enzyme 5 (UBA5) Required for Binding to Ubiquitin-like Proteins and Ufmylation.
Habisov S; Huber J; Ichimura Y; Akutsu M; Rogova N; Loehr F; McEwan DG; Johansen T; Dikic I; Doetsch V; Komatsu M; Rogov VV; Kirkin V
J Biol Chem; 2016 Apr; 291(17):9025-41. PubMed ID: 26929408
[TBL] [Abstract][Full Text] [Related]
6. Covalent Ligand Discovery against Druggable Hotspots Targeted by Anti-cancer Natural Products.
Grossman EA; Ward CC; Spradlin JN; Bateman LA; Huffman TR; Miyamoto DK; Kleinman JI; Nomura DK
Cell Chem Biol; 2017 Nov; 24(11):1368-1376.e4. PubMed ID: 28919038
[TBL] [Abstract][Full Text] [Related]
7. Reimagining Druggability Using Chemoproteomic Platforms.
Spradlin JN; Zhang E; Nomura DK
Acc Chem Res; 2021 Apr; 54(7):1801-1813. PubMed ID: 33733731
[TBL] [Abstract][Full Text] [Related]
8. UBA5 Mutations Cause a New Form of Autosomal Recessive Cerebellar Ataxia.
Duan R; Shi Y; Yu L; Zhang G; Li J; Lin Y; Guo J; Wang J; Shen L; Jiang H; Wang G; Tang B
PLoS One; 2016; 11(2):e0149039. PubMed ID: 26872069
[TBL] [Abstract][Full Text] [Related]
9. A selective inhibitor of the UFM1-activating enzyme, UBA5.
da Silva SR; Paiva SL; Bancerz M; Geletu M; Lewis AM; Chen J; Cai Y; Lukkarila JL; Li H; Gunning PT
Bioorg Med Chem Lett; 2016 Sep; 26(18):4542-4547. PubMed ID: 27520940
[TBL] [Abstract][Full Text] [Related]
10. The Ufm1-activating enzyme Uba5 is indispensable for erythroid differentiation in mice.
Tatsumi K; Yamamoto-Mukai H; Shimizu R; Waguri S; Sou YS; Sakamoto A; Taya C; Shitara H; Hara T; Chung CH; Tanaka K; Yamamoto M; Komatsu M
Nat Commun; 2011 Feb; 2():181. PubMed ID: 21304510
[TBL] [Abstract][Full Text] [Related]
11. Trans-binding of UFM1 to UBA5 stimulates UBA5 homodimerization and ATP binding.
Mashahreh B; Hassouna F; Soudah N; Cohen-Kfir E; Strulovich R; Haitin Y; Wiener R
FASEB J; 2018 May; 32(5):2794-2802. PubMed ID: 29295865
[TBL] [Abstract][Full Text] [Related]
12. Novel insights into the interaction of UBA5 with UFM1 via a UFM1-interacting sequence.
Padala P; Oweis W; Mashahreh B; Soudah N; Cohen-Kfir E; Todd EA; Berndsen CE; Wiener R
Sci Rep; 2017 Mar; 7(1):508. PubMed ID: 28360427
[TBL] [Abstract][Full Text] [Related]
13. Trans-Binding Mechanism of Ubiquitin-like Protein Activation Revealed by a UBA5-UFM1 Complex.
Oweis W; Padala P; Hassouna F; Cohen-Kfir E; Gibbs DR; Todd EA; Berndsen CE; Wiener R
Cell Rep; 2016 Sep; 16(12):3113-3120. PubMed ID: 27653677
[TBL] [Abstract][Full Text] [Related]
14. A Concerted Action of UBA5 C-Terminal Unstructured Regions Is Important for Transfer of Activated UFM1 to UFC1.
Wesch N; Löhr F; Rogova N; Dötsch V; Rogov VV
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299007
[TBL] [Abstract][Full Text] [Related]
15. [Advances in applications of activity-based chemical probes in the characterization of amino acid reactivities].
Li J; Wang G; Ye M; Qin H
Se Pu; 2023 Jan; 41(1):14-23. PubMed ID: 36633073
[TBL] [Abstract][Full Text] [Related]
16. A Dimethyl-Labeling-Based Strategy for Site-Specifically Quantitative Chemical Proteomics.
Yang F; Gao J; Che J; Jia G; Wang C
Anal Chem; 2018 Aug; 90(15):9576-9582. PubMed ID: 29989794
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of UBA5 in Cells Mimics the Phenotype of Cells Lacking UBA5.
Kumari S; Banerjee S; Kumar M; Hayashi A; Solaimuthu B; Cohen-Kfir E; Shaul YD; Rouvinski A; Wiener R
Int J Mol Sci; 2022 Jul; 23(13):. PubMed ID: 35806453
[TBL] [Abstract][Full Text] [Related]
18. Reactive-cysteine profiling for drug discovery.
Maurais AJ; Weerapana E
Curr Opin Chem Biol; 2019 Jun; 50():29-36. PubMed ID: 30897495
[TBL] [Abstract][Full Text] [Related]
19. Structure and dynamics of UBA5-UFM1 complex formation showing new insights in the UBA5 activation mechanism.
Fuchs S; Kikhney AG; Schubert R; Kaiser C; Liebau E; Svergun DI; Betzel C; Perbandt M
J Struct Biol; 2021 Dec; 213(4):107796. PubMed ID: 34508858
[TBL] [Abstract][Full Text] [Related]
20. ABPP-CoDEL: Activity-Based Proteome Profiling-Guided Discovery of Tyrosine-Targeting Covalent Inhibitors from DNA-Encoded Libraries.
Jiang L; Liu S; Jia X; Gong Q; Wen X; Lu W; Yang J; Wu X; Wang X; Suo Y; Li Y; Uesugi M; Qu ZB; Tan M; Lu X; Zhou L
J Am Chem Soc; 2023 Nov; 145(46):25283-25292. PubMed ID: 37857329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
